IBERDOMIDE HYDROCHLORIDE | N221075 | BRISTOL MYERS SQUIBB CO
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| RE49647Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Oct 7, 2034 | — | — | Yes | — | — |
| RE50917Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Oct 7, 2034 | — | — | — | — | |
| 8518972Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Jun 5, 2031 | — | Yes | Yes | — | — |
| 9221788Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Sep 25, 2033 | — | Yes | — | — | — |
| 9629849Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Aug 8, 2033 | — | — | — | — | |
| 9828361Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Feb 10, 2031 | — | Yes | Yes | — | — |
| 11529339Newly listed — daily FDA feed, not yet in monthly Orange Book edition | Sep 30, 2039 | — | — | — | — |
| Code | Date | Status |
|---|---|---|
| NCE | Aug 13, 2031 | Active |